Sort   by:  
 Page size 
Germline mutation of BRCA2 increases the lifetime risk of developing prostate cancer (PCa) by over 700%. BRCA2-mutant PCa have poorer prognosis than sporadic PCa, with rapid development of metastatic, castrate-resistant prostate cancer (mCRPC) and 5-year cancer-specific survival rates of ~50-60%1-4....

We conducted a new independent GWAS of adult glioma using 1,856 cases and 4,955 controls from 14 cohort studies belonging to the Cohort Consortium, 3 case-control studies, and 1 population-based case only study. Cases were newly diagnosed glioma [ICDO-3 codes 9380-9480 or equivalent], and control...

single nucleotide variant calls from somatic sniper, vcf format. input for subclonal reconstruction
Aligned sequence data from 14 Prostate cancer samples with BRCA2 mutations
Raw Array data from the CPCGene BRCA study
Sort   by:  
 Page size